Submitted:
05 September 2023
Posted:
15 September 2023
You are already at the latest version
Abstract
Keywords:
Introduction
Methods
Toxicity Study
Biochemical Study
Histological Study
Experimental design to measure CNS activity
Withdrawal effect following glue inhalation exposure.
Statistical Analysis
Results
| Dose (mL) | Number of Animals dead/Used | % Mortality |
|---|---|---|
| Phase I | ||
| 0.5 | 0/3 | 0 |
| 1.0 | 0/3 | 0 |
| 2.0 | 0/3 | 0 |
| Phase II | ||
| 5.0 | 0/1 | 0 |
| 10 | 0/1 | 0 |
| 20 | 1/1 | 1 |
| Organs | Observation | |
| 1 | Lung | Diffuse alveolar wall damage with moderate interstitial inflammation |
| 2 | Heart | Regular cardiac myocytes |
| 3 | Kidney | Normal glomeruli, acute tubular necrosis |
| 4 | Liver | Regular hepatocyte with moderate portal triaditis and regular central vein |
Effect of Glue Inhalation on Liver Function Test, following 28 days Sub-acute Exposure in Wistar rats.
| GROUPS | NUMBER OF ENTRY | TIME SPENT (Sec.) |
|---|---|---|
| Control (Air) | 0.17 ± 0.17 | 12.0 ± 5.71 |
| Glue (2mL) | 0.33 ± 0.21 | 10.0 ± 7.28 |
| Glue (4mL) | 0.17 ± 0.17 | 43.33 ± 11.46 |
| Glue (8mL) | 0.33 ± 0.21 | 143.17 ± 46.63ab |
| Diazepam (1.0mg/kg) | 0.33 ± 0.33 | 128.50 ± 50.93 |
| GROUPS | NUMBER OF ENTRY | TIME SPENT |
|---|---|---|
| Control (Air) | 2.67 ± 1.05 | 205.83 ± 47.97 |
| Glue (2mL) | 1.17 ± 0.17 | 239.83 ± 26.60 |
| Glue (4mL) | 3.67 ± 0.71 | 249.67 ± 9.67 |
| Glue (8mL) | 1.67 ± 0.61 | 107.67 ± 45.21 |
| Diazepam (1.0mg/kg) | 1.0 ± 0.37 | 95.17 ± 51.86 |
Discussion
Conclusion
Recommendations
Author Contributions
Funding
Data Availability Statement
Acknowledgement
Conflicts of Interest
Ethical Approval
References
- Abdullahi, S. N., Dahiru, M. M., Rabiu, D. H., and Mohammed, J. M. (2020). Toxicological effect of inhaled mosquito incense sticks smoke on the histology and biochemical responses in experimental rats. Fudma journal of sciences, 4(2), 260–268. [CrossRef]
- Arts, J. H. E., Muijser, H., Jonker, D., van de Sandt, J. J. M., Bos, P. M. J., and Feron, V. J. (2008). Inhalation toxicity studies: OECD guidelines in relation to reach and scientific developments. Experimental and Toxicologic Pathology, 60(2–3), 125–133. [CrossRef]
- Bouchatta, O., Ouhaz, Z., Ba-Mhamed, S., Kerekes, N., and Bennis, M. (2016). Acute and chronic glue sniffing effects and consequences of withdrawal on aggressive behavior. Life Sciences, 152, 14–20. [CrossRef]
- Campos, A. C., Fogaça, M. V., Aguiar, D. C., and Guimarães, F. S. (2013). Animal models of anxiety disorders and stress. Revista Brasileira de Psiquiatria, 35(SUPPL.2). [CrossRef]
- Can, A., Dao, D. T., Arad, M., Terrillion, C. E., Piantadosi, S. C., and Gould, T. D. (2012). The Mouse Forced Swim Test. JoVE, 59, e3638. [CrossRef]
- Cruz, S. L., and Bowen, S. E. (2021). The last two decades on preclinical and clinical research on inhalant effects. Neurotoxicology and Teratology, 87, 106999. [CrossRef]
- Cruz, S. L., Rivera-García, M. T., and Woodward, J. J. (2014). Review of toluene action: clinical evidence, animal studies and molecular targets. Journal of Drug and Alcohol Research, 3, 1–8. [CrossRef]
- Danjuma, A., Ibrahim Taiwo, A., and Omoniyi, S. O. (2015). Nonconventional Use of Substances among Youth in Nigeria: Viewpoints of Students in a Nigerian Tertiary Institution. Journal of Nursing and Care, 04(06). [CrossRef]
- Egbuonu, A. C. C., Egbuonu, O. N. C., and Samuel, E. S. (2016). The prevalence of some psychoactive substances use among secondary school adolescents in Bosso Local Government Area, Nigeria. Journal of Environmental Toxicology and Public Health, 1, 6–10. [CrossRef]
- Ferreira, L. L., Gomes-Filho, J., Sumida, D., Bonfim, S., Sivieri-Araujo, G., Guimarães, G., and Cintra, L. (2017). Diabetic Rats Present High Mean Platelet Count in the Presence of Oral Infections. Brazilian Dental Journal, 28, 548–551. [CrossRef]
- Abasiubong F., Udobang J. A., Idung A. U., Udoh S. B., and Jombo H. E. (2014). Pattern of psychoactive substance use in the northern region of Nigeria. African Journal of Drug and Alcohol Studies, 13(2), 107–115.
- Gerasimov, M. R., Collier, L., Ferrieri, A., Alexoff, D., Lee, D., Gifford, A. N., and Balster, R. L. (2003). Toluene inhalation produces a conditioned place preference in rats. European Journal of Pharmacology, 477(1), 45–52. [CrossRef]
- Haller, J., and Alicki, M. (2012). Current animal models of anxiety, anxiety disorders, and anxiolytic drugs. In Current Opinion in Psychiatry (Vol. 25, Issue 1, pp. 59–64). [CrossRef]
- Jatau, A. I., Sha’aban, A., Gulma, K. A., Shitu, Z., Khalid, G. M., Isa, A., Wada, A. S., and Mustapha, M. (2021). The Burden of Drug Abuse in Nigeria: A Scoping Review of Epidemiological Studies and Drug Laws. Public Health Reviews, 42, 1603960. [CrossRef]
- Jayanth, S. H., Hugar, B. S., Praveen, S., and Girish Chandra, Y. P. (2017). Glue sniffing. The Medico-Legal Journal, 85(1), 38–42. [CrossRef]
- Kazeem, Y., and Chutel, L. (2018, May 17). Africa’s desperate youth are getting high on opioids. Blueprint Newspapers Limited. https://www.blueprint.ng/africas-desperate-youth-getting-high-opioids-yomi-kazeem-lynsey-chutel/. 17 May.
- Kharchoufa, L., Bouhrim, M., Bencheikh, N., el Assri, S., Amirou, A., Yamani, A., Choukri, M., Mekhfi, H., and Elachouri, M. (2020). Acute and Subacute Toxicity Studies of the Aqueous Extract from Haloxylon scoparium Pomel (Hammada scoparia (Pomel)) by Oral Administration in Rodents. BioMed Research International, 2020. 2020. [CrossRef]
- Kilkenny C, Browne WJ, Cuthill IC et al (2013) Improving bioscienceresearch reporting: the arrive guidelines for reporting animal research. Animals 4:35–44. [CrossRef]
- Kumar, V. , Bhat, Z. A., and Kumar, D. (2013). Animal models of anxiety: A comprehensive review. In Journal of Pharmacological and Toxicological Methods (Vol. 68, Issue 2, pp. 175–183). [CrossRef]
- Kuranchie, F. A., Angnunavuri, P. N., Attiogbe, F., and Nerquaye-Tetteh, E. N. (2019). Occupational exposure of benzene, toluene, ethylbenzene and xylene (BTEX) to pump attendants in Ghana: Implications for policy guidance. Http://Www.Editorialmanager.Com/Cogentenv, 5(1). [CrossRef]
- LEE, R., and VALENTINO, D. (2021). TOLUENE-INDUCED ACUTE LUNG INJURY: CASE REPORT. Chest, 160(4), A719. [CrossRef]
- López-Rubalcava, C., Hen, R., and Cruz, S. L. (2000). Anxiolytic-like actions of toluene in the burying behavior and plus-maze tests: differences in sensitivity between 5-HT1B knockout and wild-type mice. Behavioural Brain Research, 115(1), 85–94. [CrossRef]
- Lorke, D. (1983). A New Approach to Practical Acute Toxicity Testing. Arch. Toxicol, 54(4), 275–287.
- Lynch, W. J., Nicholson, K. L., Dance, M. E., Morgan, R. W., and Foley, P. L. (2010). Animal Models of Substance Abuse and Addiction: Implications for Science, Animal Welfare, and Society. Comparative Medicine, 60(3), 177.
- Munawar, K., Choudhry, F. R., Hadi, M. A., and Khan, T. M. (2019). Prevalence of and Factors Contributing to Glue Sniffing in the South Asian Association for Regional Cooperation (SAARC) Region: A Scoping Review and Meta-analysis. Substance Use and Abuse, 55(5), 752–762. [CrossRef]
- Nath, C., Saxena, R., and Gupta, M. (2000). Effect Of Dopamine Agonists And Antagonists On The Lorazepam Withdrawal Syndrome In Rats. Clinical and Experimental Pharmacology and Physiology, 27(3), 167–171. [CrossRef]
- Nelson, R. J., and Trainor, B. C. (2007). Neural mechanisms of aggression. Nature Reviews Neuroscience, 8(7), 536–546. [CrossRef]
- Nwaji, A. R., Ante, I. A., Nwoke, F. K., and Inwang, U. (2022). Changes in Serum Electrolytes, Urea and Creatinine in Nicotiana tabacum-treated Rats. Nigerian Journal of Physiological Sciences, 37(1), 153–156. [CrossRef]
- Páez-Martı́inez, N., Cruz, S. L., and López-Rubalcava, C. (2003). Comparative study of the effects of toluene, benzene, 1,1,1-trichloroethane, diethyl ether, and flurothyl on anxiety and nociception in mice. Toxicology and Applied Pharmacology, 193(1), 9–16. [CrossRef]
- Ramlagan, S., Peltzer, K., and Matseke, G. (2010). Epidemiology of drug abuse treatment in South Africa. South African Journal of Psychiatry, 16(2), 40–49. [CrossRef]
- Saha, S., and Banerjee, S. (2013). Central nervous system stimulant actions of Alpinia galanga (L.) rhizome: A preliminary study. Indian Journal of Experimental Biology, 51, 828–832.
- Sofidiya, M. O., Alokun, A. M., Fageyinbo, M. S., and Akindele, A. J. (2022). Central nervous system depressant activity of ethanol extract of Motandra guineensis (Thonn) AD. aerial parts in mice. Phytomedicine Plus, 2(1). [CrossRef]
- Taiwo, A. E., Leite, F. B., Lucena, G. M., Barros, M., Silveira, D., Silva, M. V., and Ferreira, V. M. (2012). Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: Influence of administration and gender. Indian Journal of Pharmacology, 44(2), 189–192. [CrossRef]
- Ugbedeojo A. A., Terungwa, L. T., and Terfa, T.J. (2021). Intake and Abuse of Psychoactive Substances and Its Relative Consequences: A Review. Science Journal of Analytical Chemistry, 9(2), 39. [CrossRef]
- UNODC. (2013). The challenge of new psychoactive substances Global SMART Programme 2013 Acknowledgements.
- UNODC. (2021). UNODC Early Warning Advisory (EWA) on New Psychoactive Substances (NPS). https://www.unodc.org/LSS/Home/NPS.
- Vaugeois, J.-M., Passera, G., Zuccaro, F., and Costentin, J. (1997). Individual differences in response to imipramine in the mouse tail suspension test. Psychopharmacology, 134(4), 387–391. [CrossRef]
- Vitale, C. M., and Gutovitz, S. (2018). Aromatic Toxicity. StatPearls. http://europepmc.org/books/NBK532257.
- Wallace, P. S., and Taylor, S. P. (2009). Reduction of appeasement-related affect as a concomitant of diazepam-induced aggression: evidence for a link between aggression and the expression of self-conscious emotions. Aggressive Behavior, 35(2), 203–212. [CrossRef]
- Yan, H. C., Cao, X., Das, M., Zhu, X. H., and Gao, T. M. (2010). Behavioral animal models of depression. In Neuroscience Bulletin (Vol. 26, Issue 4, pp. 327–337). [CrossRef]





| Parameters | Control (Air) | Glue (2ml) | Glue (4ml) | Glue (8ml) |
|---|---|---|---|---|
| Total Bilirubin (mg/dL) | 3.15 ± 0.23 | 3.61± 0.16 | 5.25 ± 0.51ab | 6.62 ± 0.39ab |
| Direct Bilirubin (mg/dL) | 1.64 ± 0.14 | 1.55 ± 0.08d | 2.02 ± 0.34d | 3.00 ± 0.14a |
| ALP (u/L) | 42.63 ± 2.49 | 71.79 ± 6.35a | 102.49 ± 6.06ab | 115.07 ± 4.66ab |
| AST (u/L) | 63.51 ± 8.57 | 72.92 ± 18.54 | 81.65 ± 17.32 | 80.13 ± 19.50 |
| ALT (u/L) | 22.48 ± 0.68 | 72.20± 8.61ac | 96.60 ± 2.19ad | 67.63 ± 0.64ac |
| Total Protein (g/dL) | 6.00 ± 0.13 | 6.45 ± 0.22 | 6.95 ± 0.78 | 9.07 ± 0.86ab |
| Cholesterol (mg/dL) | 216.64 ± 8.99 | 136.22 ± 12.47ac | 198.97 ± 10.35 | 153.46 ±10.40ac |
| Glucose (mmol/L) | 6.36 ± 0.25 | 5.96 ± 0.34 | 5.56 ± 0.30 | 6.72 ± 0.55 |
| Albumin (g/L) | 3.56 ± 0.17 | 3.56 ± 0.17 | 3.94 ± 0.11 | 3.65 ± 0.18 |
| Parameter | Control (Air) | Glue (2ml) | Glue (4ml) | Glue (8ml) |
|---|---|---|---|---|
| Urea (mmol/L) | 7.36 ± 0.58 | 9.06 ± 0.58 | 9.06 ± 0.55 | 10.20 ± 0.82a |
| Creatinine (µmol/L) | 198.54 ± 20.60 | 218.82 ± 18.59 | 145.99 ± 10.88b | 172.38 ± 12.23 |
| Na+ (mmol/L) | 141.08 ± 1.37 | 145.05 ± 1.99 | 145.67 ± 2.18 | 145.55 ± 2.58 |
| K+ (mmol/L) | 4.63 ± 0.14 | 4.55 ± 0.13a | 4.73 ± 0.18a | 5.00 ± 0.10a |
| HCO3 (mmol/L) | 17.53 ± 0.28 | 20.50 ± 0.41a | 19.67 ± 0.42a | 21.10 ± 0.52a |
| Parameters | Control (Air) | Glue (2mL) | Glue (4mL) | Glue (8mL) |
|---|---|---|---|---|
| White Blood Cell (10^9/L) | 21.65 ± 1.49 | 21.96 ± 1.43 | 22.60 ± 1.77 | 22.26 ± 1.74 |
| Red Blood Cell (10^12/L) | 6.79 ± 0.65 | 7.28 ± 0.23 | 7.03 ± 0.22 | 7.34 ± 0.24 |
| Haemoglobin (g/dL) | 14.58 ± 0.35 | 15.20 ± 0.36 | 14.67 ± 0.46 | 15.00 ± 0.37 |
| Haematocrit (%) | 37.28 ±1.10 | 37.87 ± 1.05 | 36.42 ± 1.23 | 37.62 ± 1.44 |
| Platelet (10^9/L) | 625.33 ± 33.89 | 614.00± 24.03 | 663.33 ± 44.17 | 699.00 ± 43.42 |
| Granulocyte (%) | 32.87 ± 3.82 | 24.85 ± 1.53 | 25.58 ± 2.20 | 23.35 ± 1.88 |
| Lymphocyte (%) | 67.78 ± 1.67 | 70.23 ± 0.86 | 71.80 ± 3.61 | 70.25 ± 1.44 |
| GROUPS | ORGANS | MICROSCOPIC OBSERVATION |
|---|---|---|
|
Group I Control (air) |
Lungs | Normal regular alveoli space and interstitium. |
| Liver | Normal, portal triad, central vein, and hepatocytes | |
| Kidney | Normal glomeruli, tubules and interstitium. | |
| Heart | Regular cardiac myocytes | |
| Brain | Normal neurophils | |
| Eye | Normal conjunctiva, cornea, and retina | |
|
Group II Glue (2mL) |
Lungs | Regular alveolar spaces with mild interstitial inflammation |
| Liver | Normal, portal triad, central vein, and hepatocytes | |
| Kidney | Normal glomeruli, tubules and interstitium | |
| Heart | Regular cardiac myocytes | |
| Brain | Regular neurophils | |
| Eye | Normal conjunctiva, cornea, and retina | |
|
Group III Glue (4mL) |
Lungs | Regular alveolar spaces with moderate interstitial inflammation |
| Liver | Regular hepatocyte with mild portal triaditis and regular central vein | |
| Kidney | Normal glomeruli, tubules and interstitium | |
| Heart | Regular cardiac myocytes | |
| Brain | Regular neurophils | |
| Eye | Normal conjunctiva, cornea, and retina | |
|
Group IV Glue (8mL) |
Lungs | Regular alveolar spaces with moderate interstitial inflammation |
| Liver | Regular hepatocyte with moderate portal triaditis and regular central vein | |
| Kidney | Normal glomeruli, tubules and interstitium | |
| Heart | Regular cardiac myocytes | |
| Brain | Regular neurophils | |
| Eye | Normal conjunctiva, cornea, and retina |
| GROUPS | NUMBER OF HEAD DIPS |
|---|---|
| Control (Air) | 8.0 ± 2.57 |
| Glue (2mls) | 12.0 ± 3.11c |
| Glue (4mls) | 25.5 ± 3.27a |
| Glue (8mls) | 12.3 ± 2.64c |
| Diazepam 1.0mg/kg | 9.0 ± 3.82c |

| GROUPS | DURATION OF IMMOBILITY (Sec.) |
|---|---|
| Control (Air) | 135.83 ± 14.24 |
| Glue (2mL) | 87.17 ± 26.21c |
| Glue (4mL) | 173.33 ± 9.77f |
| Glue (8mL) | 32.50 ± 14.51ac |
| Imipramine (10mg/kg) | 45.50 ± 9.11a |
| Groups (mL) | Base Line | Main Test | ||
|---|---|---|---|---|
| TSDC (Sec.) | TSWC (Sec.) | TSDC (Sec.) | TSWC (Sec.) | |
| Control (Air) | 507.50 ± 118.00 | 331.83 ± 110.62 | 507.50 ± 118.00 | 331.83 ± 110.62 |
| Glue (2mL) | 721.33 ± 75.23 | 152.00 ± 65.23 | 650.33 ± 150.09 | 237.17 ± 150.59 |
| Glue (4mL) | 663.17 ± 36.52 | 164.67 ± 20.75 | 719.33 ± 25.22 | 140.17 ± 22.95 |
| Glue (8mL) | 583.50 ± 125.80 | 156.50 ± 113.96 | 612.17 ± 130.81 | 227.50 ± 129.67 |
| Parameters | Control (Air) | Glue (2ml) | Glue (4ml) | Glue (8ml) |
|---|---|---|---|---|
| Total Bilirubin (mg/dL) | 0.55 ± 0.01 | 1.34± 0.07acd | 0.58 ± 0.01d | 2.52 ± 0.11a |
| Direct Bilirubin (mg/dL) | 0.31 ± 0.02 | 0.76 ± 0.01acd | 0.42 ± 0.01ad | 1.54 ± 0.01d |
| ALP (u/L) | 55.66 ± 1.81 | 74.06 ± 1.32ad | 66.24 ± 1.89ad | 86.02 ± 3.14a |
| AST (u/L) | 32.02 ± 1.56 | 46.67 ± 0.16ad | 48.33 ± 0.07ad | 65.45 ± 0.09a |
| ALT (u/L) | 43.13 ± 0.33 | 68.65± 0.41acd | 75.25 ± 0.07ad | 26.35 ± 0.11a |
| Total Protein (g/dL) | 6.64 ± 0.03 | 7.08 ± 0.01acd | 5.59 ± 0.11ad | 7.76 ± 0.02a |
| Albumin (g/L) | 1.18 ± 0.00 | 2.11 ± 0.01acd | 1.66 ± 0.01ad | 1.38 ± 0.00a |
| Parameter | Control (Air) | Glue (2ml) | Glue (4ml) | Glue (8ml) |
|---|---|---|---|---|
| Urea (mmol/L) | 17.77 ± 0.09 | 21.05 ± 1.01 | 24.62 ± 3.90 | 18.73 ± 0.06 |
| Creatinine (µmol/L) | 110.27 ± 0.31 | 167.34 ± 0.54ad | 181.71 ± 9.78ad | 136.41 ± 0.31a |
| Na+ (mmol/L) | 132.00 ± 1.34 | 138.67 ± 1.30ad | 140.83 ± 0.48ad | 133.33 ± 1.28 |
| K+ (mmol/L) | 3.80 ± 0.07 | 4.33 ± 0.10ad | 4.60 ± 0.08a | 3.32 ± 0.10ac |
| HCO3 (mmol/L) | 17.53 ± 0.28 | 23.22 ± 0.15ad | 23.25 ± 0.29ad | 20.75 ± 0.23 |
| Parameters | Control (Air) | Glue (2ml) | Glue (4ml) | Glue (8ml) |
|---|---|---|---|---|
| White Blood Cell (10^9/L) | 17.13 ± 0.57 | 12.14 ± 1.02a | 18.73 ± 1.94b | 14.43 ± 1.14 |
| Red Blood Cell (10^12/L) | 7.69 ± 0.25 | 7.92 ± 0.29 | 7.40 ± 0.17 | 7.86 ± 0.11 |
| Haemoglobin (g/dL) | 14.83 ± 0.28 | 15.27 ± 0.43 | 14.45 ± 0.27 | 15.05 ± 0.23 |
| Haematocrit (%) | 42.55 ±0.48 | 45.67 ± 0.99a | 41.22 ± 0.52b | 42.05 ± 0.83b |
| Platelet (10^9/L) | 494.67 ± 12.40 | 691.83 ± 22.97 | 598.83 ± 114.50 | 813.67 ± 41.17a |
| Granulocyte (%) | 22.18 ± 0.98 | 28.93 ± 2.21 | 24.37 ± 0.97 | 32.95 ± 4.56a |
| Lymphocyte (%) | 74.73 ± 1.34 | 68.82 ± 2.48 | 66.57 ± 2.10 | 62.18 ± 2.62 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).